Prostate Cancer
Conditions
Brief summary
Biochemical recurrence rate within two years after surgery, defined as a PSA > 0.2 ng/ml.
Detailed description
- Total number of ePLNDs and PSMA PET/CTs performed and their intervention-related healthcare costs, costs of complication-related interventions and associated (prolonged) hospital stay. - Biochemical persistence, defined as PSA >0.1 within half a year after surgery - Surgical complications within 6 months after surgery. - Total nodes resected on ePLND and number of positive and negative nodes within and outside of the standard ePLND template. The necessity for a second PSMA PET / CT.
Interventions
Sponsors
Canisius Wilhelmina Ziekenhuis
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical recurrence rate within two years after surgery, defined as a PSA > 0.2 ng/ml. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Total number of ePLNDs and PSMA PET/CTs performed and their intervention-related healthcare costs, costs of complication-related interventions and associated (prolonged) hospital stay. - Biochemical persistence, defined as PSA >0.1 within half a year after surgery - Surgical complications within 6 months after surgery. - Total nodes resected on ePLND and number of positive and negative nodes within and outside of the standard ePLND template. The necessity for a second PSMA PET / CT. | — |
Countries
Netherlands
Outcome results
None listed